Skip to main content
. 2018;19(1):131–139. doi: 10.22034/APJCP.2018.19.1.131

Table 3.

Apoptosis Percentage. The effect of eupatorin, salvigenin and doxorubicin on apoptosis in A) HT-29 and B) SW948. Flow cytometry detection of apoptosis with Annexin V/PI. The median of three independent experiments is shown. Eup= eupatorin and sal= salvigenin. *Significantly different from control cells (*P<0.05, **P<0.01, ***P<0.001), ¥ significantly different from eupatorin (¥P<0.05 and ¥¥P<0.01) and ψ significantly different from salvigenin (ψP<0.05 and ψψψP<0.001).

A

HT-29 cell line control Dox Eupatorin Salvigenin Dox(1µM)+Eup Dox(1µM)+Sal
Necrosis 3.37±0.18 18.33±1.17 ** 5.63±0.26 * 2.36±0.12 * 7.30±0.84 * 18.9±1.7 **
late apoptosis 0.297±.019 66.6±5.97 *** 46.5±2.97 ** 9.46±0.88 * 83.2±5.36 ***, ¥¥ 71.3±4.97 ***,ψψψ
Early apoptosis 0.872±.028 5.31±0.49 ** 4.80±0.36 ** 13.80±1.02 *** 3.16±0.28 ** 3.18±0.24 **,ψ
Viable cells 95.5±3.66 6.58±0.51 *** 43±4.39 ** 74.4±4.64 ** 6.38±0.78 ***,¥¥ 2.90±0.16 ***,ψψψ

B

SW948 cell line control Dox (10µM) Eupatorin Salvigenin Dox(1µM)+Eup Dox(1µM)+Sal

Necrosis 0.869±0.059 16.33±1.89 ** 4.44±0.36 * 6.02±0.45 * 11±0.92 **,¥ 5.26±0.32 *
late apoptosis 0.363±0.019 72.8±4.15 *** 20.7±2.01 ** 19.9±1.5 ** 49.4±3.18 ***,¥¥ 63.44±4.61 ***,ψψψ
Early apoptosis 1.17±0.07 2.31±0.18 * 27.1±2.08 *** 20.9±1.32 ** 19.6±0.89 **,¥ 7.9±0.52 *,ψψψ
Viable cells 97.6±5.19 6.58±0.37 *** 44.4±2.87 ** 48.36±3.02 ** 16.19±0.98 *,¥¥ 22.1±1.14 *,ψψψ